These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 5011751)

  • 1. Activation of the first component of complement evidence for an internal activation step.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Mar; 108(3):683-8. PubMed ID: 5011751
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 4. Differentiation of binding from complete activation by use of heterologous components of complement.
    Koethe SM; Austen KF; Gigli I
    J Immunol; 1972 Apr; 108(4):1063-72. PubMed ID: 5023166
    [No Abstract]   [Full Text] [Related]  

  • 5. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.
    Gaither TA; Alling DW; Frank MM
    J Immunol; 1974 Aug; 113(2):574-83. PubMed ID: 4210883
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract]   [Full Text] [Related]  

  • 7. The first component of complement in serum: evidence for a hitherto unrecognized factor in C1 necessary for internal activation.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1973 Jan; 110(1):205-12. PubMed ID: 4685401
    [No Abstract]   [Full Text] [Related]  

  • 8. The first component of human complement (C1): kinetics of reaction with its natural substrates.
    Strunk R; Colten HR
    J Immunol; 1974 Mar; 112(3):905-10. PubMed ID: 4811969
    [No Abstract]   [Full Text] [Related]  

  • 9. Further evidence for immune cytolysis by antibody and the first eight components of complement in the absence of C9.
    Tamura N; Shimada A; Chang S
    Immunology; 1972 Jan; 22(1):131-40. PubMed ID: 5013908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis.
    Gaither TA; Frank MM
    J Immunol; 1973 Feb; 110(2):482-9. PubMed ID: 4684035
    [No Abstract]   [Full Text] [Related]  

  • 11. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A; Boumsell L; Borsos
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An explanation for the inefficiency of guinea pig complement in the cytolysis of sheep erythrocytes or rat mast cells sensitized with rabbit antiserum: a double block.
    Kempf RA; Gigli I; Austen KF
    Transplant Proc; 1969 Mar; 1(1):626-8. PubMed ID: 4109231
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1671-7. PubMed ID: 4750864
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on the mechanism of immune hemolysis: importance of immunoglobulin class and source of complement on the extent of damage.
    Frank MM; Dourmashkin RR; Humphrey JH
    J Immunol; 1970 Jun; 104(6):1502-10. PubMed ID: 5452415
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.
    Phillips JK; Snyderman R; Mergenhagen SE
    J Immunol; 1972 Aug; 109(2):334-41. PubMed ID: 4114826
    [No Abstract]   [Full Text] [Related]  

  • 17. Automation of immune hemolytic and complement reactions by AutoAnalyzer. II.
    Vargues R; Henley W
    Mt Sinai J Med; 1974; 41(3):453-79. PubMed ID: 4134099
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation and partial characterization of sheep erythrocyte-antibody-complement intermediate.
    Rommel FA; Stolfi R
    Immunology; 1968 Oct; 15(4):469-79. PubMed ID: 5696260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    Ruddy S; Austen KF
    J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.
    Goldlust MB; Shin HS; Hammer CH; Mayer MM
    J Immunol; 1974 Sep; 113(3):998-1007. PubMed ID: 4213402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.